Lead party: Oncologie Diagnostic du Maroc (lead investor/buyer)
Coverage: Meridian Capital (investment and transaction tracker; data from Partner Researchers, editorially reviewed).
Target: Clinique Badr (private company) · Sector: Healthcare, Health Care Administration, Specialty Healthcare Providers · Countries of operation: Morocco
Transaction type: Investment · Asset class: Corporate Transactions · Strategy: Buyout · Instrument: Equity · Equity stake: 0.75%
Lead investor/buyer: Oncologie Diagnostic du Maroc · Investors/buyers: Oncologie Diagnostic du Maroc
Legal advisers: not identified in the source record.
Source: announced 22 July 2019. Original announcement: medias24.com.


